查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1485251

临床化学分析仪市场- 副产品（试剂[缓衝液、对照品]、分析仪[台式、落地式]）、测试（基本代谢、肝臟、肾臟、血脂分析）、模式（集中式、分散式）、最终用途- 全球2024 - 2032 年预测

Clinical Chemistry Analyzers Market - By Product (Reagents [Buffer, Control], Analyzers [Benchtop, Floor-standing]), Test (Basic Metabolic, Liver, Renal, Lipid Profile), Modality (Centralized, Decentralized), End-use - Global Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在慢性病盛行率上升、老年人口增加以及医疗基础设施投资不断增加的推动下，全球临床化学分析仪市场在 2024 年至 2032 年期间将以 4.1% 的复合年增长率成长。

世界卫生组织 (WHO) 最近的一份报告显示，非传染性疾病 (NCD) 目前约占全球每年死亡人数的 75%。随着糖尿病、心血管疾病和肾臟疾病等疾病在全球范围内变得越来越普遍，对准确、及时的诊断解决方案的需求越来越大。临床化学分析仪透过测量患者样本中的各种生物标记和参数，在诊断和监测这些慢性病方面发挥着至关重要的作用。随着慢性病负担持续升级，对临床化学分析仪的需求可能会增加，从而推动市场成长。此外，检测技术的进步以及用于检测和管理慢性病的新型检测方法的开发进一步促进了市场的扩张。

临床化学分析仪市场根据产品、测试、模式、最终用途和地区进行分类。

由于集中式分析仪能够有效处理大量样本，集中式分析仪细分市场将在预测期内显着成长。这些分析仪提供自动化测试程序、缩短週转时间并提高准确性，从而提高实验室的整体生产力。随着对集中检测设施简化诊断流程和改善患者护理的需求不断增长，预计该细分市场将进一步成长。

到 2032 年，肝臟检测领域将累积相当大的临床化学分析仪市场份额，因为肝臟检测对于评估肝臟的整体健康和功能至关重要。肝臟检测包括一组生物标记，如丙胺酸转氨酶(ALT)、天门冬胺酸转氨酶(AST)、胆红素和碱性磷酸酶(ALP) 等，有助于诊断和监测各种肝臟疾病，包括肝炎、肝硬化、及肝癌。随着饮酒、肥胖和病毒感染等因素的推动，全球肝病盛行率不断上升，对肝臟检测的需求显着增加。

在医疗保健基础设施快速扩张、医疗保健支出增加以及人们对早期疾病诊断重要性的认识不断提高的支持下，亚太地区临床化学分析仪行业预计在 2024 年至 2032 年期间实现大幅增长。中国、印度和日本等国家正在医疗保健技术和基础设施方面进行大量投资，推动先进诊断解决方案的采用，包括临床化学分析仪。此外，慢性病的日益普及正在扩大对诊断服务的需求，从而推动不同医疗保健环境的市场成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 老年人口不断增加
      • 慢性疾病和生活方式疾病的盛行率不断增加
      • 越来越多地采用现场护理测试设备
      • 对实验室自动化的需求不断增长
    • 产业陷阱与挑战
      • 仪器成本高
      • 资金投入要求高
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

  • 主要趋势
  • 试剂
    • 缓衝器
    • 校准器
    • 控制
    • 标准
    • 其他试剂
  • 分析仪
    • 依技术
      • 半自动分析仪
      • 全自动分析仪
      • 护理点分析仪
    • 按类型
      • 桌上型分析仪
      • 落地式分析仪
  • 其他产品

第 6 章：市场估计与预测：按测试类型，2018 年 - 2032 年

  • 主要趋势
  • 基础代谢组
  • 肝臟面板
  • 肾臟概况
  • 脂质谱
  • 甲状腺功能面板
  • 电解板
  • 特种化学测试

第 7 章：市场估计与预测：按模式，2018 年 - 2032 年

  • 主要趋势
  • 集中
  • 去中心化

第 8 章：市场估计与预测：按最终用途，2018 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 专科诊所
  • 诊断实验室
  • 其他最终用户

第 9 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • Abbott Laboratories
  • Danaher Corporation
  • EKF Diagnostics
  • F.Hoffmann-La Roche Ltd.
  • Hitachi Ltd.
  • HORIBA Ltd.
  • Ortho Clinical Diagnostics
  • QuidelOrtho Corporation
  • Siemens Healthineers AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
简介目录
Product Code: 8435

Global Clinical Chemistry Analyzers Market will grow at 4.1% CAGR during 2024-2032, driven by the rising prevalence of chronic diseases, increasing geriatric population, and growing investments in healthcare infrastructure.

A recent World Health Organization (WHO) report shows that non-communicable diseases (NCDs) now account for approximately 75% of global deaths annually. With conditions such as diabetes, cardiovascular diseases, and kidney disorders becoming more prevalent globally, there is an increasing need for accurate and timely diagnostic solutions. Clinical chemistry analyzers play a crucial role in diagnosing and monitoring these chronic conditions by measuring various biomarkers and parameters in patient samples. As the burden of chronic diseases continues to escalate, the demand for clinical chemistry analyzers could rise, driving market growth. Additionally, advancements in testing technologies and the development of novel assays for detecting and managing chronic diseases further contribute to the market expansion.

The Clinical Chemistry Analyzers Market is classified based on product, test, modality, end-use, and region.

The centralized analyzers segment will register significant growth during the forecast period due to the ability of centralized analyzers to handle a high volume of samples efficiently. These analyzers offer automated testing procedures, reduced turnaround time, and enhanced accuracy, thus improving overall laboratory productivity. With the growing demand for centralized testing facilities to streamline diagnostic processes and improve patient care, further segment growth is expected.

Liver panel segment will amass a decent Clinical Chemistry Analyzers Market Share by 2032 as the liver panel test is vital in assessing the overall health and function of the liver. Comprising a panel of biomarkers such as alanine transaminase (ALT), aspartate transaminase (AST), bilirubin, and alkaline phosphatase (ALP), among others, liver panel tests aid in the diagnosis and monitoring of various hepatic conditions, including hepatitis, cirrhosis, and liver cancer. With the rising prevalence of liver diseases globally, fueled by factors such as alcohol consumption, obesity, and viral infections, the demand for liver panel testing is witnessing a notable upsurge.

Asia Pacific Clinical Chemistry Analyzers industry is poised for substantial growth over 2024-2032, supported by a rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and rising awareness regarding the importance of early disease diagnosis. Countries like China, India, and Japan are making significant investments in healthcare technology and infrastructure, driving the adoption of advanced diagnostic solutions, including clinical chemistry analyzers. Furthermore, the growing prevalence of chronic diseases is amplifying the demand for diagnostic services, thereby propelling market growth across diverse healthcare settings.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising geriatric population
      • 3.2.1.2 Increasing prevalence of chronic disorders and lifestyle diseases
      • 3.2.1.3 Growing adoption of point of care testing devices
      • 3.2.1.4 Increasing demand for laboratory automation
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of instruments
      • 3.2.2.2 Requirement for high capital investment
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Reagents
    • 5.2.1 Buffers
    • 5.2.2 Calibrators
    • 5.2.3 Controls
    • 5.2.4 Standards
    • 5.2.5 Other reagents
  • 5.3 Analyzers
    • 5.3.1 By technology
      • 5.3.1.1 Semi-automatic analyzers
      • 5.3.1.2 Fully automatic analyzers
      • 5.3.1.3 Point of care analyzers
    • 5.3.2 By type
      • 5.3.2.1 Benchtop analyzers
      • 5.3.2.2 Floor-standing analyzers
  • 5.4 Other products

Chapter 6 Market Estimates and Forecast, By Test Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Basic metabolic panel
  • 6.3 Liver panel
  • 6.4 Renal profile
  • 6.5 Lipid profile
  • 6.6 Thyroid function panel
  • 6.7 Electrolyte panel
  • 6.8 Speciality chemical tests

Chapter 7 Market Estimates and Forecast, By Modality, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Centralized
  • 7.3 Decentralized

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Specialty clinics
  • 8.4 Diagnostic laboratories
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories
  • 10.2 Danaher Corporation
  • 10.3 EKF Diagnostics
  • 10.4 F.Hoffmann-La Roche Ltd.
  • 10.5 Hitachi Ltd.
  • 10.6 HORIBA Ltd.
  • 10.7 Ortho Clinical Diagnostics
  • 10.8 QuidelOrtho Corporation
  • 10.9 Siemens Healthineers AG
  • 10.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 10.11 Sysmex Corporation
  • 10.12 Thermo Fisher Scientific Inc.